BGLC - BioNexus Gene Lab Corp


2.67
0.010   0.375%

Share volume: 26,467
Last Updated: 05-07-2025
Healthcare/Services – Health: -0.02%

PREVIOUS CLOSE
CHG
CHG%

$2.66
0.01
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 03-31-2023 06-30-2023 09-30-2023 12-31-2023 03-31-2024 06-30-2024 09-30-2024
Fiscal Quarter Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024
Report Date 05-15-2024 08-16-2023 03-26-2024 11-15-2024 05-15-2024 08-14-2024 11-15-2024
Total revenue 2.377 M 2.567 M 2.554 M 2.273 M 2.382 M 1.975 M 2.630 M
Cost of revenue 2.008 M 2.227 M 2.199 M 2.007 M 2.017 M 1.686 M 2.304 M
Gross profit 368.897 K 339.714 K 354.332 K 266.555 K 365.031 K 288.720 K 326.536 K
    -7.91% 4.30% -24.77% 36.94% -20.91% 13.10%  
Operating expenses 536.872 K 807.077 K 3.082 M -16.955 K 645.906 K 759.657 K 2.130 M
Selling general and admin 536.872 K 807.077 K 3.082 M -16.955 K 645.906 K 759.657 K 2.130 M
Research and development 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Total expenses 536.872 K 611.913 K 3.082 M -307.827 K 645.906 K 29.552 K 2.130 M
    13.98% 403.69% -109.99% 309.83% -95.42% 7,106.57%  
Operating income -50.631 K -272.199 K -2.529 M 257.754 K -79.028 K 259.168 K -1.338 M
Ebit 48.278 K -275.241 K -2.329 M -47.067 K 98.090 K 254.688 K -872.095 K
Pretax income -53.076 K -275.241 K -2.533 M 253.571 K -83.689 K 254.688 K -1.344 M
    418.58% 820.20% -110.01% -133.00% -404.33% -627.63%  
Income tax 0.000 15.990 K 76.418 K 0.000 0.000 -55.584 K 1.555 K
Net income basic 0.000 0.000 0.000 0.000 0.000 0.000 0.000
                 
Net income -69.066 K -259.251 K -2.609 M 308.463 K -103.757 K 199.104 K -1.345 M
    -275.37% -906.43% 111.82% -133.64% 291.89% -775.71%